A Comparison of the Effects of Risperidone, Raclopride, and Ritanserin on Intravenous Self-Administration of d-Amphetamine
Data up to Jan 2025
Total Citations Per Year
Abstract
References (45)
Brain Dopamine and Reward
1989 • 1,899 citations
Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy
1996 • 1,301 citations
Reconciling the role of central serotonin neurons in human and animal behavior
1986 • 989 citations
On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine
1977 • 733 citations
Destruction of dopaminergic nerve terminals in nucleus accumbens: Effect on d-amphetamine self-administration
1979 • 460 citations
Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
1985 • 444 citations
Dopaminergic substrates of amphetamine-induced place preference conditioning
1982 • 381 citations
Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors
1993 • 334 citations
Self-administration of d-amphetamine by rats
1968 • 303 citations
Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat.
1994 • 299 citations
Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition
1989 • 266 citations
Fluoxetine reduces intravenous cocaine self-administration in rats
1990 • 254 citations
Self-administration of cocaine on a progressive ratio schedule in rats: dose-response relationship and effect of haloperidol pretreatment
1989 • 240 citations
Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin
1990 • 231 citations
Parameters of self-administration of cocaine in rats under a progressive-ratio schedule
1993 • 217 citations
The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions
1986 • 215 citations
Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat
1991 • 172 citations
The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas
1991 • 161 citations
Mode of Action of Atypical Neuroleptics in Relation to the Phencyclidine Model of Schizophrenia: Role of 5-HT2 Receptor and α1-Adrenoreceptor Antagonism
1995 • 154 citations
Ritanserin, a Selective 5-HT2/1C Antagonist, and Negative Symptoms in Schizophrenia
1993 • 153 citations
Behavioral and 5-HT antagonist effects of ritanserin: A pure and selective antagonist of LSD discrimination in rat
1985 • 143 citations
Pharmacological profile of ritanserin: A very specific central serotonin S2‐antagonist
1988 • 139 citations
Cocaine self-administration is increased by both D1 and D2 dopamine antagonists
1991 • 138 citations
Increased self-administration of d-amphetamine after destruction of 5-hydroxytryptaminergic neurons
1980 • 122 citations
The effects of putative 5-hydroxytryptamine receptor active agents ond-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesion
1984 • 102 citations
Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration
1991 • 97 citations
An open clinical and biochemical study of ritanserin in acute patients with schizophrenia
1994 • 97 citations
Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectively in the mesolimbic dopaminergic system
1995 • 90 citations
Lesions of central serotonin systems affect responding on a progressive ratio schedule reinforced either by intravenous cocaine or by food
1994 • 87 citations
Serotonergic regulation of associative learning
1995 • 83 citations
Dietary tryptophan supplements attenuate amphetamine self-administration in the rat
1986 • 70 citations
Ritanserin, a new therapeutic approach for drug abuse. Part 1: Effects on alcohol
1991 • 67 citations
MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine
1993 • 65 citations
Effects of ritanserin on the rewarding properties of d-amphetamine, morphine and diazepam revealed by conditioned place preference in rats
1988 • 55 citations
5-HT-sub-2 receptor involvement in conditioned olfactory learning in the neonate rat pup.
1996 • 47 citations
5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.
1992 • 45 citations
5-HT₂ receptor involvement in conditioned olfactory learning in the neonate rat pup.
1996 • 42 citations
A Rodent Model for Nicotine Self-Administration
2003 • 41 citations
Pharmacological validation of ritanserin and risperidone in the drug discrimination test procedure in the rat
1990 • 39 citations
Ritanserin, a new therapeutic approach for drug abuse. Part 2: Effects on cocaine
1992 • 29 citations
Anatomical substrates for neuroleptic-induced reward attenuation and neuroleptic-induced response decrement
1991 • 27 citations
Increased self-administration of d-amphetamine by rats pretreated with metergoline
1983 • 20 citations
Mixed D2/5-HT2A antagonism of amphetamine-induced facilitation of brain stimulation reward
1995 • 17 citations
D2 and 5‐HT2 modulation of psychostimulant‐induced facilitation of brain stimulation reward
1995 • 9 citations
Potentiation of the effects of raclopride on sucrose consumption by the 5-HT2 antagonist ritanserin
1996 • 6 citations